Novo... 4202 snoisses cifitneics ADA t

Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions of the American Diabetes Association (ADA). The confere... Stay informed with the latest.
Policy & Regulation
上一篇:Why... ygolonhceT edisffO RAV esU t'n
下一篇:Croatia... 61 fO dnuoR 4202 oruE oT ylatI